Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 131,762 | 127,224 | 113,826 | 114,302 | 115,743 |
| Operating Income | -131,762 | -127,224 | -113,826 | -114,302 | -115,743 |
| Other Income | 5,854 | 7,524 | 7,961 | 3,332 | 6,702 |
| Pre-tax Income | -125,908 | -119,700 | -105,865 | -110,970 | -109,041 |
| Income Tax | 594 | 913 | 584 | 152 | 78 |
| Net Income Continuous | -126,502 | -120,613 | -106,449 | -111,122 | -109,119 |
| Net Income | $-126,502 | $-120,613 | $-106,449 | $-111,122 | $-109,119 |
| EPS Basic Total Ops | -0.73 | -0.71 | -0.63 | -0.76 | -0.74 |
| EPS Basic Continuous Ops | -0.73 | -0.71 | -0.63 | -0.76 | -0.75 |
| EPS Diluted Total Ops | -0.73 | -0.71 | -0.63 | -0.76 | -0.74 |
| EPS Diluted Continuous Ops | -0.73 | -0.71 | -0.63 | -0.76 | -0.75 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.60 | -0.64 | -0.76 | -0.74 |
| EBITDA(a) | $-131,657 | $-127,117 | $-113,717 | $-114,203 | $-115,654 |